Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
Objective: While primary cytoreductive surgery (PCS) is considered the standard of care for women who present with stage IV endometrial cancer, neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery (ICS) has emerged as an alternative treatment strategy. We summarized the literat...
Guardado en:
Autores principales: | Allan B. Huang, Jenny Wu, Ling Chen, Benjamin B. Albright, Rebecca A. Previs, Haley A. Moss, Brittany A. Davidson, Laura J. Havrilesky, Alexander Melamed, Jason D. Wright |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/487cccd14cec469c978d5f218e10b84c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
por: Mitchell Clark, et al.
Publicado: (2021) -
Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Sangam Jha, et al.
Publicado: (2021) -
Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
por: Daiken Osaku, et al.
Publicado: (2021) -
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?
por: Manolis Nikolopoulos, et al.
Publicado: (2021) -
Endometrial hyperplasia: without atypia and with atypia
por: Maksim A. Sabantsev, et al.
Publicado: (2021)